+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tyrosine Market Research Reports

Tyrosine Protein Kinase Lck Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Tyrosine Protein Kinase Lck Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 38 Pages
  • Global
From
Tyrosine Protein Kinase Lyn Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Tyrosine Protein Kinase Lyn Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 39 Pages
  • Global
From
Tyrosine Protein Kinase BTK Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Tyrosine Protein Kinase BTK Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 112 Pages
  • Global
From
Cells Expressing Tyrosine Protein Kinase Receptor UFO Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Cells Expressing Tyrosine Protein Kinase Receptor UFO Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 37 Pages
  • Global
From
Tyrosine Protein Kinase Receptor UFO Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Tyrosine Protein Kinase Receptor UFO Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 68 Pages
  • Global
From
Receptor Tyrosine Protein Kinase ERBB 3 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Receptor Tyrosine Protein Kinase ERBB 3 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 54 Pages
  • Global
From
Cells Expressing ALK Tyrosine Kinase Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Cells Expressing ALK Tyrosine Kinase Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 35 Pages
  • Global
From
Inactive Tyrosine Protein Kinase Transmembrane Receptor ROR1 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Inactive Tyrosine Protein Kinase Transmembrane Receptor ROR1 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 36 Pages
  • Global
From
Tyrosine Protein Kinase ABL1 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Tyrosine Protein Kinase ABL1 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 43 Pages
  • Global
From
Cells Expressing Receptor Type Tyrosine Protein Kinase FLT3 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Cells Expressing Receptor Type Tyrosine Protein Kinase FLT3 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 41 Pages
  • Global
From
Proto Oncogene Tyrosine Protein Kinase Receptor Ret Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Proto Oncogene Tyrosine Protein Kinase Receptor Ret Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 80 Pages
  • Global
From
Receptor Type Tyrosine Protein Kinase FLT3 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Receptor Type Tyrosine Protein Kinase FLT3 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 113 Pages
  • Global
From
Cells Expressing Receptor Tyrosine Protein Kinase ERBB 2 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Cells Expressing Receptor Tyrosine Protein Kinase ERBB 2 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 248 Pages
  • Global
From
Bcr-Abl Tyrosine Kinase Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Bcr-Abl Tyrosine Kinase Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 61 Pages
  • Global
From
Receptor Tyrosine Protein Kinase ERBB 2 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Receptor Tyrosine Protein Kinase ERBB 2 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 173 Pages
  • Global
From
ALK Tyrosine Kinase Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

ALK Tyrosine Kinase Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 67 Pages
  • Global
From
Cells Expressing Inactive Tyrosine Protein Kinase Transmembrane Receptor ROR1 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Cells Expressing Inactive Tyrosine Protein Kinase Transmembrane Receptor ROR1 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 54 Pages
  • Global
From
Cells Expressing Receptor Tyrosine Protein Kinase ERBB 3 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Cells Expressing Receptor Tyrosine Protein Kinase ERBB 3 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 49 Pages
  • Global
From
Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 100 Pages
  • Global
From
Tyrosine decarboxylase (CAS 9002-09-9) Global Market Research Report 2024 - Product Thumbnail Image

Tyrosine decarboxylase (CAS 9002-09-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Loading Indicator

The Tyrosine market is a sector of the pharmaceutical industry that focuses on the production and sale of tyrosine, an essential amino acid. Tyrosine is used in the production of proteins, hormones, and neurotransmitters, and is also used in the treatment of certain medical conditions. It is available in both synthetic and natural forms. The Tyrosine market is highly competitive, with many companies offering a variety of products. Companies in the market include Merck, Pfizer, Novartis, GlaxoSmithKline, and Sanofi. These companies produce a range of products, from tablets and capsules to powders and liquids. They also offer a variety of delivery methods, such as oral, topical, and intravenous. The Tyrosine market is constantly evolving, with new products and technologies being developed to meet the needs of consumers. Companies in the market are continually striving to improve their products and services, in order to remain competitive. Show Less Read more